British American Tobacco (BTI) AI Stock Analysis

Compare

5,031 Followers

Top Page

British American Tobacco

(NYSE:BTI)

Select Model

Neutral 52 (OpenAI - 4o)

Rating:52Neutral

Price Target:

$53.00

▲(3.60% Upside)

The overall stock score of 52 reflects British American Tobacco's stable financial structure and attractive dividend yield, offset by challenges in revenue growth, profitability, and bearish technical indicators. The absence of earnings call and corporate events data limits further insights into strategic direction.

British American Tobacco (BTI) vs. SPDR S&P 500 ETF (SPY)

Market Cap

$110.91B

Dividend Yield5.84%

Average Volume (3M)4.02M

Price to Earnings (P/E)28.6

Beta (1Y)0.10

Revenue Growth0.48%

EPS GrowthN/A

CountryUS

Employees48,989

SectorConsumer Defensive

Sector Strength42

IndustryTobacco

Share Statistics

EPS (TTM)2.15

Shares Outstanding2,185,746,300

10 Day Avg. Volume3,895,361

30 Day Avg. Volume4,017,811

Financial Highlights & Ratios

PEG Ratio-0.17

Price to Book (P/B)1.29

Price to Sales (P/S)2.48

P/FCF Ratio6.75

Enterprise Value/Market Cap1.32

Enterprise Value/Revenue5.72

Enterprise Value/Gross Profit6.86

Enterprise Value/Ebitda18.18

Forecast

1Y Price Target

$51.00

Price Target Upside-0.31% Downside

Rating ConsensusHold

Number of Analyst Covering2

British American Tobacco Business Overview & Revenue Model

Company DescriptionBritish American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

How the Company Makes MoneyBritish American Tobacco generates revenue primarily through the sale of its tobacco products, including cigarettes and other traditional tobacco items, which remain the largest portion of its income. The company has also been expanding its revenue streams through next-generation products (NGPs), which include e-cigarettes and heated tobacco products, catering to the growing market of consumers looking for reduced-risk alternatives. Key revenue streams include direct sales to retailers, wholesalers, and distributors, as well as partnerships with various stakeholders in the tobacco and NGP sector. Additionally, BAT invests in innovation, marketing, and distribution strategies to enhance its product offerings and increase market share, contributing significantly to its earnings.

British American Tobacco Key Performance Indicators (KPIs)

Any

Adjusted Profit from Operations by Geography

Adjusted Profit from Operations by Geography
Shows profit performance across different regions, highlighting areas of strong operational efficiency and potential challenges due to local market conditions or regulatory environments.

Chart InsightsBritish American Tobacco's adjusted profit from operations shows a notable shift with the US consistently leading, albeit with some fluctuations. AME and APMEA regions have recently emerged as significant contributors, while APME and AMSSA have seen their contributions cease. This geographic reallocation suggests a strategic pivot towards markets with higher growth potential, potentially driven by regulatory changes or shifting consumer preferences. The absence of recent earnings commentary leaves the underlying reasons open to interpretation, but the data indicates a clear realignment of focus within the company's operational strategy.

Data provided by:

Main Street Data

British American Tobacco Earnings Call Summary

Earnings Call Date:Jul 31, 2025

(Q4-2024)

% Change Since: |

Next Earnings Date:Feb 05, 2026

Earnings Call Sentiment Neutral

The earnings call presented a balanced view of achievements and challenges. Notable improvements in new category growth, financial flexibility, and a path to recovery in the U.S. were highlighted. However, significant challenges in the vapor market and headwinds in Bangladesh and Australia present concerns. The overall sentiment leans towards cautious optimism, with confidence in strategic investments and future growth prospects.

Q4-2024 Updates

Positive Updates

Transformation Momentum and Financial Flexibility

The company sharpened execution and delivered improved performance in the second half of the year, with smokeless accounting for 17.5% of group revenue, up 1 percentage point versus last year. New category contribution improved by GBP251 million and a 7 percentage point increase in category contribution margin on an organic constant rates basis.

New Category Revenue Growth

Group revenue grew by 1.3%, and new category revenue grew by 8.9%. Adjusted operating profit rose 1.4%, and diluted EPS increased by 3.6%. Modern Oral revenue grew 53% in 2024, with strong growth across all regions.

Commitment to Shareholder Returns

Progress in financial flexibility enabled the initiation of sustainable share buyback, with leverage within the target range at 2.4 times, alongside a progressive dividend with 2% growth announced.

Strong Performance in Europe

New category growth enabled the European business to exceed group mid-term revenue guidance, with significant increases in absolute category contribution through scale and efficiencies.

U.S. Market Recovery

Investments in the U.S. market have begun to pay off, with volume share stabilizing and plans for a return to growth in 2025, despite macroeconomic pressures and illicit trade challenges.

Negative Updates

Challenges in the Vapor Market

Vapor revenue fell by 2.5% due to weak enforcement against illicit single-use vapes in the U.S. and Canada, distorting competition. The U.S. volumes declined by 4%, and without stronger enforcement, illicit vapor products will continue to impact the legal market.

Impact of Market Exits and Supply Chain Issues

Organic volumes declined 5% in combustibles, mainly due to U.S. market exits and supply chain issues in Sudan. Excluding these, volume declined 3.5%.

Headwinds in Bangladesh and Australia

Significant headwinds in Bangladesh due to sharp excise increases and illicit trade, and in Australia due to new tobacco regulations and rising illicit trade, expected to impact 2025 group revenue growth by 1% and group APFO growth by close to 2%.

Pressure from Macro and Illicit Trade in the U.S.

The U.S. revenue declined by 3.4% due to ongoing macroeconomic pressures impacting affordability and illicit vapor products affecting both combustibles and vapor.

Company Guidance

In the recent call, the company provided guidance for 2025 and 2026, indicating an expected group revenue growth of around 1% for 2025, impacted by significant headwinds in Bangladesh and Australia, which will affect group revenue by 1% and group adjusted profit from operations (APFO) by close to 2%. Despite these challenges, the company remains committed to achieving a 3% to 5% revenue growth and a 4% to 6% APFO growth, adjusted for Canada at constant rates, by 2026. This optimism is underpinned by expectations of an improving U.S. financial performance, further growth in new categories, and significant cost efficiencies, targeting an additional GBP2 billion in savings by 2030. Additionally, the company plans to continue rewarding shareholders with a progressive dividend and sustainable share buybacks while maintaining a balanced capital allocation.

British American Tobacco Financial Statement Overview

Summary

British American Tobacco demonstrates resilience in its financial structure with zero debt in 2024 and a strong asset base. However, challenges in revenue growth and profitability, highlighted by a negative net profit margin and stagnating revenue, impact its financial performance score.

Income Statement

Neutral

British American Tobacco's income statement reveals mixed performance. The gross profit margin remains robust at 82.8%, indicating strong cost management. However, the company has faced challenges with volatile net income, evident from the negative net profit margin of -52.7% in 2023, primarily due to a significant EBIT loss. Recent revenue growth has been stagnating, with a 5.19% decline from 2022 to 2023, raising concerns about future growth prospects.

Balance Sheet

Neutral

The balance sheet reflects a stable financial position with zero debt in 2024, which is a positive turnaround from previous years. The equity ratio is healthy at 41.8%, showcasing a solid capital structure. However, the return on equity has been inconsistent, with a significant drop in 2023 due to negative net income. The company's asset base remains strong, supporting long-term stability.

Cash Flow

Neutral

Cash flow analysis indicates steady operational cash generation, with a 5.5% increase in free cash flow from 2023 to 2024. The operating cash flow to net income ratio was significantly impacted in 2023 due to negative net income, but the free cash flow has remained positive, reflecting effective cash management despite earnings volatility.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	25.60B	25.87B	27.28B	27.66B	25.68B	25.78B
Gross Profit	21.34B	21.43B	22.39B	22.85B	21.09B	21.33B
EBITDA	8.05B	7.74B	13.28B	12.38B	11.19B	10.71B
Net Income	3.09B	3.07B	-14.37B	6.67B	6.80B	6.40B
Balance Sheet
Total Assets	110.23B	118.90B	118.72B	153.55B	137.37B	137.69B
Cash, Cash Equivalents and Short-Term Investments	4.89B	5.81B	2.96B	4.03B	3.27B	3.38B
Total Debt	35.33B	36.95B	39.73B	43.14B	39.66B	43.97B
Total Liabilities	63.05B	68.90B	65.78B	77.84B	69.96B	74.73B
Stockholders Equity	46.87B	49.64B	52.57B	75.37B	67.10B	62.67B
Cash Flow
Free Cash Flow	8.67B	9.52B	10.25B	9.87B	9.19B	9.28B
Operating Cash Flow	9.27B	10.13B	10.71B	10.39B	9.72B	9.79B
Investing Cash Flow	954.00M	1.38B	-296.00M	-705.00M	-1.14B	-783.00M
Financing Cash Flow	-11.39B	-10.63B	-9.31B	-8.88B	-8.75B	-7.90B

British American Tobacco Technical Analysis

Technical Analysis Sentiment

Negative

Last Price51.16

Price Trends

50DMA

54.15

Negative

100DMA

51.62

Negative

200DMA

45.26

Positive

Market Momentum

MACD

-0.74

Negative

RSI

40.66

Neutral

STOCH

62.62

Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BTI, the sentiment is Negative. The current price of 51.16 is below the 20-day moving average (MA) of 51.55, below the 50-day MA of 54.15, and above the 200-day MA of 45.26, indicating a neutral trend. The MACD of -0.74 indicates Negative momentum. The RSI at 40.66 is Neutral, neither overbought nor oversold. The STOCH value of 62.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BTI.

British American Tobacco Risk Analysis

British American Tobacco disclosed 41 risk factors in its most recent earnings report. British American Tobacco reported the most risks in the "Legal & Regulatory" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added 0 New Risks

British American Tobacco Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PM	71 Outperform	$246.03B	29.99	―	3.49%	7.44%	-6.72%
MO	68 Neutral	$109.28B	12.57	―	6.40%	-0.18%	-10.69%
RLX	67 Neutral	$2.92B	29.20	4.56%	0.33%	61.64%	16.76%
UVV	64 Neutral	$1.33B	13.05	7.20%	6.11%	4.11%	-15.50%
TPB	64 Neutral	$1.58B	37.96	26.05%	0.34%	4.44%	-5.94%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BTI	52 Neutral	$110.91B	28.57	5.97%	5.84%	0.48%	―

* Consumer Defensive Sector Average

Performance Comparison

BTI

British American Tobacco

51.16

18.62

57.22%

Altria Group

64.40

17.74

38.02%

Philip Morris

158.06

31.38

24.77%

UVV

Universal

53.35

5.49

11.47%

TPB

Turning Point Brands

87.68

42.85

95.58%

RLX

RLX Technology

2.39

0.77

47.53%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025